Reduced-dose rituximab in rheumatoid arthritis: Efficacy depends on degree of B cell depletion-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reduced-dose rituximab in rheumatoid arthritis: Efficacy depends on degree of B cell depletion

Published:2011-02-25 Issue:3 Volume:63 Page:603-608
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Vital Edward M.,Rawstron Andrew C.,Dass Shouvik,Henshaw Karen,Madden Julie,Emery Paul,McGonagle Dennis

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.30152/fullpdf

Reference17 articles.

1. Pharmacokinetics of rituximab and its clinical use: thought for the best use?;Cartron;Crit Rev Oncol Hematol,2007

2. Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion;Leandro;Ann Rheum Dis,2002

3. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial;Emery;Arthritis Rheum,2006

4. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis;Felson;Arthritis Rheum,1995

5. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria;Van Gestel;Arthritis Rheum,1996

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR T cell therapy for refractory pediatric systemic lupus erythematosus: a new era of hope?;Pediatric Rheumatology;2024-08-08

2. Patients' and rheumatologists' perceptions on dose reduction of rituximab in rheumatoid arthritis;Musculoskeletal Care;2024-05

3. Do the Outcomes of Clinical Efficacy Trials Matter in Regulatory Decision-Making for Biosimilars?;BioDrugs;2023-10-13

4. Should complete B cell depletion be maintained in patients treated long-term with rituximab for rheumatoid arthritis?;Rheumatology;2023-10-04

5. POS0636 SHOULD COMPLETE B-CELL DEPLETION BE SUSTAINED IN RITUXIMAB LONG-TERM TREATED PATIENTS FOR RHEUMATOID ARTHRITIS?;Scientific Abstracts;2023-05-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3